ROIX — Response Oncology Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Response Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1997 December 31st | C1998 December 31st | C1999 December 31st | 2000 December 31st | 2001 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K405 | 10-K405 | 10-K405 | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 4.2 | -17.4 | -1.69 | -14.4 | -51.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.12 | 39.2 | 5.25 | 17.8 | 46.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.44 | -8.17 | 2.81 | 4.43 | 12.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 6.57 | 2.78 | 12.8 | 5.12 | 9.1 |
| Capital Expenditures | -0.978 | -1.7 | -0.741 | -0.645 | -0.125 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.259 | -1.01 | 0 | 0.087 | 0.135 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | -1.24 | -2.71 | -0.741 | -0.558 | 0.01 |
| Financing Cash Flow Items | -0.388 | -0.805 | -1.17 | -0.392 | -0.939 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3.33 | -1.41 | -5.94 | -4.43 | -8.52 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.01 | -1.34 | 6.11 | 0.132 | 0.587 |